Concepts (88)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Natural Killer T-Cells | 8 | 2023 | 124 | 1.480 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 1 | 2018 | 47 | 0.630 |
Why?
|
| L-Selectin | 2 | 2018 | 34 | 0.610 |
Why?
|
| beta Catenin | 2 | 2023 | 688 | 0.510 |
Why?
|
| Carcinoma, Papillary | 1 | 2018 | 584 | 0.480 |
Why?
|
| Neuroblastoma | 4 | 2023 | 686 | 0.470 |
Why?
|
| Receptors, Antigen | 2 | 2016 | 76 | 0.260 |
Why?
|
| Immunotherapy, Adoptive | 5 | 2023 | 1763 | 0.240 |
Why?
|
| Cytotoxicity, Immunologic | 4 | 2023 | 675 | 0.230 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2023 | 26 | 0.230 |
Why?
|
| Lymphoma, B-Cell | 2 | 2018 | 895 | 0.190 |
Why?
|
| Lymphocyte Activation | 4 | 2023 | 1688 | 0.190 |
Why?
|
| Pancreatic Neoplasms | 1 | 2018 | 5061 | 0.190 |
Why?
|
| Cancer Vaccines | 2 | 2014 | 697 | 0.170 |
Why?
|
| Mice, SCID | 3 | 2023 | 1869 | 0.170 |
Why?
|
| Mice, Inbred NOD | 2 | 2023 | 905 | 0.160 |
Why?
|
| Antigen-Presenting Cells | 2 | 2016 | 284 | 0.160 |
Why?
|
| Mutation | 1 | 2018 | 15179 | 0.160 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2023 | 1538 | 0.150 |
Why?
|
| Th1 Cells | 1 | 2018 | 250 | 0.150 |
Why?
|
| Antigens, CD1d | 2 | 2014 | 32 | 0.150 |
Why?
|
| Interleukins | 1 | 2018 | 325 | 0.140 |
Why?
|
| Salmonella typhimurium | 1 | 2014 | 70 | 0.120 |
Why?
|
| Vaccines, Attenuated | 1 | 2014 | 210 | 0.120 |
Why?
|
| Mice | 8 | 2023 | 34495 | 0.100 |
Why?
|
| Cells, Cultured | 2 | 2018 | 5637 | 0.100 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2016 | 1555 | 0.090 |
Why?
|
| Neoplasms | 3 | 2023 | 15193 | 0.090 |
Why?
|
| Immunotherapy | 2 | 2014 | 3341 | 0.090 |
Why?
|
| Cytokines | 2 | 2016 | 2809 | 0.090 |
Why?
|
| Cell Survival | 1 | 2016 | 3045 | 0.090 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2011 | 247 | 0.080 |
Why?
|
| Medulloblastoma | 1 | 2013 | 540 | 0.080 |
Why?
|
| Antigens, Neoplasm | 1 | 2014 | 1506 | 0.080 |
Why?
|
| Animals | 8 | 2023 | 59536 | 0.080 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2016 | 3821 | 0.080 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2011 | 426 | 0.070 |
Why?
|
| Cell Line, Tumor | 3 | 2018 | 14551 | 0.070 |
Why?
|
| Mice, Knockout | 1 | 2016 | 5710 | 0.070 |
Why?
|
| Cell Proliferation | 2 | 2016 | 7226 | 0.070 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2023 | 6550 | 0.060 |
Why?
|
| Humans | 12 | 2023 | 261506 | 0.060 |
Why?
|
| Etanercept | 1 | 2023 | 54 | 0.060 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2023 | 37 | 0.060 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2023 | 77 | 0.060 |
Why?
|
| Protein Domains | 1 | 2023 | 314 | 0.050 |
Why?
|
| Antigens, CD19 | 1 | 2023 | 577 | 0.050 |
Why?
|
| Prognosis | 1 | 2018 | 21713 | 0.040 |
Why?
|
| Adolescent | 2 | 2018 | 31252 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2023 | 1021 | 0.040 |
Why?
|
| Monocytes | 1 | 2023 | 788 | 0.040 |
Why?
|
| Galactosylceramides | 1 | 2018 | 34 | 0.040 |
Why?
|
| Granzymes | 1 | 2018 | 91 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2018 | 173 | 0.040 |
Why?
|
| Killer Cells, Natural | 1 | 2023 | 904 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2023 | 1146 | 0.040 |
Why?
|
| Carcinogenesis | 1 | 2023 | 1026 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 2018 | 1519 | 0.030 |
Why?
|
| Interleukin-2 | 1 | 2018 | 842 | 0.030 |
Why?
|
| 4-1BB Ligand | 1 | 2014 | 15 | 0.030 |
Why?
|
| Gangliosides | 1 | 2014 | 95 | 0.030 |
Why?
|
| Retroviridae | 1 | 2014 | 332 | 0.030 |
Why?
|
| CD28 Antigens | 1 | 2014 | 202 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2014 | 475 | 0.030 |
Why?
|
| Molecular Typing | 1 | 2011 | 55 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 1487 | 0.020 |
Why?
|
| Bacterial Typing Techniques | 1 | 2011 | 139 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2023 | 3869 | 0.020 |
Why?
|
| Molecular Epidemiology | 1 | 2011 | 246 | 0.020 |
Why?
|
| China | 1 | 2011 | 606 | 0.020 |
Why?
|
| Female | 2 | 2018 | 141928 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2014 | 1029 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2011 | 1053 | 0.020 |
Why?
|
| Antitubercular Agents | 1 | 2011 | 318 | 0.020 |
Why?
|
| Macrophages | 1 | 2014 | 1304 | 0.020 |
Why?
|
| Child | 2 | 2023 | 29154 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2011 | 994 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2014 | 1586 | 0.020 |
Why?
|
| Cell Line | 1 | 2014 | 5114 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 5112 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2014 | 2819 | 0.010 |
Why?
|
| Graft vs Host Disease | 1 | 2014 | 2638 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2013 | 6150 | 0.010 |
Why?
|
| Genotype | 1 | 2011 | 4109 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2013 | 16273 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 32848 | 0.010 |
Why?
|
| Male | 2 | 2013 | 123000 | 0.010 |
Why?
|
| Middle Aged | 1 | 2011 | 86204 | 0.000 |
Why?
|